Launching Saliva Detection Test For Oral Cancer, Perirx Sees Opportunity For Early-Stage Disease Dx

PeriRx, a Pennsylvania-based developer of non-invasive oral diagnostic technology, has launched SaliMark OSCC, which it said is the first commercial saliva test for the early detection of oral squamous cell carcinoma.

The test kit contains biomarkers identified in an initial study done by the Early Detection Research Network (EDRN), an initiative of the National Cancer Institute. The biomarkers and the test were pre-validated by David Wong, a professor in the University of California at Los Angeles' School of Dentistry. A prospective blind study using the kit as a testing method was also performed by researchers at PeriRx the results of which were published in the May 2015 volume of the Compendium of Continuing Education in Dentistry.

Hey, check out all the engineering jobs. Post your resume today!

Back to news